How to Enroll in a Retatrutide (GLP-3) Clinical Trial
FAQ-000089
Direct Answer
The only current, legal way to access retatrutide is through enrollment in an active clinical trial. Eli Lilly's ongoing TRIUMPH and related trials are listed publicly on ClinicalTrials.gov, the official U.S. government registry of clinical studies, where you can search by condition, location, and eligibility criteria.
What Trial Enrollment Actually Involves
Legitimate trial participation includes a formal informed consent process, defined eligibility criteria you'll be screened against, real safety monitoring throughout the study, and no patient-paid cost for the medication itself, since trial participants don't purchase the drug, they receive it as part of the study.
How to Actually Search
On ClinicalTrials.gov, search for "retatrutide" directly, or search by the medication's development code, LY3437943, to find current listings. Filter by your location and check each listing's specific eligibility criteria carefully, trials often have real, specific requirements around BMI, existing health conditions, and prior treatment history.
Why This Is the Only Legitimate Path Right Now
Since retatrutide isn't FDA-approved, there's no prescription pathway and no legal compounding option, covered in more detail on our grey-market safety warning. Clinical trial enrollment is genuinely the only route that includes real medical oversight and a documented safety framework.
Bottom Line
If you're specifically interested in trying retatrutide before approval, clinical trial enrollment through ClinicalTrials.gov is the real, legitimate path, not a grey-market purchase, and it comes with genuine oversight and no direct medication cost.
References
- ClinicalTrials.gov: Official U.S. Clinical Trial Registry
Related Resources
- Is Retatrutide FDA-Approved Yet? Current Status
- Is Grey-Market Retatrutide (GLP-3) Safe? What Poison Control Data Shows
Explore More
Explore the full GLP-1 Tracker knowledge base on DietApp.com
Get Started
Track retatrutide alongside every other GLP-1 medication on DietApp.com.
About DietApp.com
DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. Retatrutide is investigational and not FDA-approved. This article is for general informational purposes and is not medical advice.
how-to-enroll-retatrutide-glp-3-clinical-trial